Intensive Case Diabetes Management (ICDM) to Prevent Readmission
- Conditions
- Diabetes
- Registration Number
- NCT02230488
- Lead Sponsor
- Washington University School of Medicine
- Brief Summary
The purpose of this study is to assess whether intensive case management interventions by a diabetes team, led by an endocrinologist and certified diabetes educator, can prevent \<31 day readmission in previously identified high risk patients with diabetes.The procedures of the study will focus on managing the patient's diabetes and diabetes education while in the hospital, decreasing the patient's risk for hypoglycemia and hyperglycemia in the hospital, and assist in the patient's diabetes management plan for a safe discharge.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 1
- Patients admitted with a diagnosis of diabetes, Patients with a previous history of Pharmacy Expert System (PES) alert, Enrollment in research must be within 24 hours of admission
- Patients transferred from institutionalized care, Patients who already plan to move to institutionalized care, Patients with severe co-morbidities (e.g. terminal cancer), Patients admitted for surgery within 24 hours, Patients who are unwilling or unable to give written consent (e.g. dementia), Patients who are homeless, Patients previously admitted to the diabetes endocrine service
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Prevent <31 day readmission The length of time between hospital discharge and readmission 31 days Primary outcome measure is to assess whether an intensive case management intervention by a diabetes team, led by an endocrinologist and a certified diabetes educator (CDE) , can prevent a \<31 day readmission in previously identified high risk patients with diabetes compared to standard/usual care.
- Secondary Outcome Measures
Name Time Method improve overall glycemic management Upon the participant's consent (within 24 hours of hospital admission) to hospital discharge- the average length of stay is five days To examine whether intensive case management intervention per endocrinologist and CDE during hospital stay prevents hypoglycemia \<70mg/dl, severe hypoglycemia \<40mg/dl, and improves overall glycemic management (100-180 mg/dl) compared to standard/usual care.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Barnes-Jewish Hospital
🇺🇸St. Louis, Missouri, United States
Barnes-Jewish Hospital🇺🇸St. Louis, Missouri, United States